A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer-Reference-Cited by-同舟云学术

A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer

Published:2023-08-05 Issue:7 Volume:129 Page:1176-1183
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Hashimoto Taiki^ORCID,Takayanagi Daisuke^ORCID,Yonemaru Junpei,Naka Tomoaki,Nagashima Kengo^ORCID,Machida Erika,Kohno Takashi,Yatabe Yasushi^ORCID,Kanemitsu Yukihide,Hamamoto Ryuji^ORCID,Takashima Atsuo^ORCID,Shiraishi Kouya^ORCID,Sekine Shigeki^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-023-02382-z.pdf

Reference35 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

2. Fabregas JC, Ramnaraign B, George TJ. Clinical updates for colon cancer care in 2022. Clin Colorectal Cancer. 2022;21:198–203.

3. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001;2:127–37.

4. Arteaga CL, Sliwkowski MX, Osborne CK, Perez EA, Puglisi F, Gianni L. Treatment of HER2-positive breast cancer: current status and future perspectives. Nat Rev Clin Oncol. 2011;9:16–32.

5. Boku N. HER2-positive gastric cancer. Gastric Cancer. 2014;17:1–12.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2 amplification subtype intrahepatic cholangiocarcinoma exhibits high mutation burden and T cell exhaustion microenvironment;Journal of Cancer Research and Clinical Oncology;2024-08-28

2. Resistance to Anti-HER2 Therapies in Gastrointestinal Malignancies;Cancers;2024-08-15

3. HER2-targeted therapies beyond breast cancer — an update;Nature Reviews Clinical Oncology;2024-07-22

4. Temporal and spatial heterogeneity of HER2 status in metastatic colorectal cancer;Diagnostic Pathology;2024-06-22

5. Advances in Precision Medicine Approaches for Colorectal Cancer: From Molecular Profiling to Targeted Therapies;ACS Pharmacology & Translational Science;2024-03-19